Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of **folate** (in the form of L-5-methyltetrahydrofolic acid, glucosamine salt) and **curcumin** (as a high-purity curcuminoid complex) used primarily in prescription medical food formulations such as Rheumate. This combination is designed for dietary management of the metabolic effects of methotrexate therapy (e.g., in chronic inflammatory diseases). Folate addresses the increased metabolic requirement and competitive inhibition of reduced folate synthesis due to methotrexate, while curcumin provides antioxidant activity to help counteract drug-induced oxidative stress. Some formulations (often as nanoparticles or carrier systems) utilize folate for targeted delivery to cells over-expressing the folate receptor, as seen in certain cancer therapy research, thereby improving curcumin's cellular uptake and bioavailability[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on folate + curcumin.